1. Home
  2. RYTM
  3. RYTM News

Latest Rhythm Pharmaceuticals Inc. (RYTM) News on November 4, 2025

Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead?
RYTM

Insider Monkey

a month ago

Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead?

3 Stocks That May Be Undervalued By Up To 49%
RYTM

Simply Wall St.

a month ago

3 Stocks That May Be Undervalued By Up To 49%

2 Under-the-Radar Stocks That Could Soar
RYTM

Motley Fool

a month ago

2 Under-the-Radar Stocks That Could Soar

FDA Priority Review for Setmelanotide in Hypothalamic Obesity Might Change The Case For Investing In Rhythm Pharmaceuticals (RYTM)
RYTM

Simply Wall St.

2 months ago

FDA Priority Review for Setmelanotide in Hypothalamic Obesity Might Change The Case For Investing In Rhythm Pharmaceuticals (RYTM)

RYTM

MT Newswires

2 months ago

Rhythm Pharma's Setmelanotide sNDA for Hypothalamic Obesity Accepted by FDA

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
RYTM

GlobeNewswire

2 months ago

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025
RYTM

GlobeNewswire

4 months ago

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues
RYTM

Investor's Business Daily

5 months ago

This IBD 50 Biotech's Got 'Rhythm' — And Flashes 3 Telltale Clues

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target
RYTM

Insider Monkey

5 months ago

Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target

RYTM

Newsfile

5 months ago

Max Resource Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025

RYTM

Newsfile

5 months ago

Carbone Restaurant Group is a GOLD Sponsor at the Centurion One Capital 6th Annual LA Summit

RYTM

Energy Global

5 months ago

European Energy completes sale of Polish wind portfolio to Enea Group

RYTM

Newsfile

5 months ago

Sienna Resources Inc. Announces Private Placement

First Foundation Bank review (2025): Personal and business banking with competitive online rates
RYTM

Yahoo Personal Finance

5 months ago

First Foundation Bank review (2025): Personal and business banking with competitive online rates

RYTM

Investing.com

5 months ago

Airbnb shares dip as Truist cuts stock to Sell on weak summer trends, valuation

Report: Slower economy doesn't dim downtown Austin's dynamism
RYTM

Austin American-Statesman

5 months ago

Report: Slower economy doesn't dim downtown Austin's dynamism

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance
RYTM

GuruFocus.com

5 months ago

Nvidia (NVDA) Gets Wall Street Boost on Strong Q1 Results and Upbeat Guidance

Funds Go All In On Weight-Loss Leader; Stock Nears Highs
RYTM

Investor's Business Daily

5 months ago

Funds Go All In On Weight-Loss Leader; Stock Nears Highs

Exploring 3 High Growth Tech Stocks In The US Market
RYTM

Simply Wall St.

5 months ago

Exploring 3 High Growth Tech Stocks In The US Market

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program
RYTM

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces New Data Presentations on Patients with Acquired or Congenital Hypothalamic Obesity (N=35) Treated with Setmelanotide for up to Nine Months in French Early-access Program

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ...
RYTM

GuruFocus.com

6 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q1 2025 Earnings Call Highlights: Strong IMCIVREE Sales and ...

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
RYTM

Zacks

6 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates

RYTM

MT Newswires

6 months ago

Rhythm Pharmaceuticals' Q1 Net Loss Narrows, Revenue Increases

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update
RYTM

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Update

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
RYTM

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

RYTM

MT Newswires

6 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $438,946, According to a Recent SEC Filing

RYTM

MT Newswires

6 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $457,663, According to a Recent SEC Filing

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for
RYTM

Zacks

6 months ago

Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for

Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know
RYTM

Zacks

6 months ago

Will Rhythm Pharmaceuticals, Inc. (RYTM) Report Negative Earnings Next Week? What You Should Know

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last?
RYTM

Zacks

6 months ago

Rhythm Pharmaceuticals (RYTM) Moves 5.2% Higher: Will This Strength Last?

Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025
RYTM

GlobeNewswire

6 months ago

Rhythm Pharmaceuticals to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $1,082,497, According to a Recent SEC Filing

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $1,248,490, According to a Recent SEC Filing

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade
RYTM

Investor's Business Daily

7 months ago

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

5 Stocks in Nasdaq ETF Fueling Index's Big Comeback Since 2008
RYTM

Zacks

7 months ago

5 Stocks in Nasdaq ETF Fueling Index's Big Comeback Since 2008

RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study
RYTM

Zacks

7 months ago

RYTM Stock Rises 17% on Meeting Goals in Hypothalamic Obesity Study

RYTM

MT Newswires

7 months ago

Morgan Stanley Raises Price Target on Rhythm Pharmaceuticals to $77 From $72, Keeps Overweight Rating

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?
RYTM

Zacks

7 months ago

Rhythm Pharmaceuticals (RYTM) Surges 17.1%: Is This an Indication of Further Gains?

Exploring 3 High Growth Tech Stocks In The US Market
RYTM

Simply Wall St.

7 months ago

Exploring 3 High Growth Tech Stocks In The US Market

This Obesity Drug Just Crushed Expectations -- And Sent One Biotech Stock Soaring 14.5%
RYTM

GuruFocus.com

7 months ago

This Obesity Drug Just Crushed Expectations -- And Sent One Biotech Stock Soaring 14.5%

Rhythm seeks market expansion for Imcivree following Phase III victory
RYTM

Clinical Trials Arena

7 months ago

Rhythm seeks market expansion for Imcivree following Phase III victory

Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder
RYTM

Benzinga

7 months ago

Rhythm Pharmaceuticals Weight Loss Drug Study Shows Significant BMI Reduction For Rare Type Of Obesity Disorder

Obesity drug data helps Rhythm defy market slide
RYTM

BioPharma Dive

7 months ago

Obesity drug data helps Rhythm defy market slide

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals' Obesity Treatment Meets Main Goal in Phase 3 Study, Shares Rise

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
RYTM

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity
RYTM

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity

RYTM

MT Newswires

7 months ago

Rhythm Pharmaceuticals Regains Licensing Rights to Imcivree Obesity Drug

Is Rhythm Pharmaceuticals (RYTM) a Worst High-Risk High-Reward Growth Stock to Buy?
RYTM

Insider Monkey

7 months ago

Is Rhythm Pharmaceuticals (RYTM) a Worst High-Risk High-Reward Growth Stock to Buy?

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.
RYTM

GlobeNewswire

7 months ago

Rhythm Pharmaceuticals Reacquires Licensing Rights to IMCIVREE® (setmelanotide) in China with Termination of Agreement with RareStone Ltd.

RYTM

MT Newswires

8 months ago

Rhythm Gets Orphan Drug Label for Setmelanotide in Japan

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan
RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

RYTM

MT Newswires

8 months ago

Rhythm Pharmaceuticals Insider Sold Shares Worth $3,861,272, According to a Recent SEC Filing

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration
RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals and Raymond A. Wood Foundation Announce Research Collaboration

US High Growth Tech Stocks to Watch in March 2025
RYTM

Simply Wall St.

8 months ago

US High Growth Tech Stocks to Watch in March 2025

We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth
RYTM

Simply Wall St.

8 months ago

We Think Rhythm Pharmaceuticals (NASDAQ:RYTM) Can Afford To Drive Business Growth

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line
RYTM

Simply Wall St.

8 months ago

Rhythm Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
RYTM

GuruFocus.com

8 months ago

Rhythm Pharmaceuticals Inc (RYTM) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

RYTM

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Rhythm Pharmaceuticals Inc Earnings Call

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates
RYTM

Zacks

8 months ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates

RYTM

MT Newswires

8 months ago

Rhythm Pharmaceuticals Q4 Loss Widens, Revenue Increases

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update
RYTM

GlobeNewswire

8 months ago

Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50
RYTM

Investor's Business Daily

8 months ago

These Biotech Stocks Aren't Profitable But Still Make Elite IBD 50

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
RYTM

Zacks

8 months ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025
RYTM

GlobeNewswire

9 months ago

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on Wednesday, February 26, 2025

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February
RYTM

GlobeNewswire

9 months ago

Rhythm Pharmaceuticals to Present at Oppenheimer Annual Healthcare Life Sciences Conference in February

Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet
RYTM

Zacks

9 months ago

Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet

Exploring High Growth Tech Stocks in January 2025
RYTM

Simply Wall St.

9 months ago

Exploring High Growth Tech Stocks in January 2025

Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?
RYTM

Zacks

9 months ago

Rhythm Pharmaceuticals (RYTM) Soars 5.5%: Is Further Upside Left in the Stock?

Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones
RYTM

GlobeNewswire

10 months ago

Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones

Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential
RYTM

TipRanks

10 months ago

Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential

RYTM

MT Newswires

10 months ago

Jefferies Initiates Rhythm Pharmaceuticals at Buy With $80 Price Target

Exploring 3 High Growth Tech Stocks In The United States
RYTM

Simply Wall St.

10 months ago

Exploring 3 High Growth Tech Stocks In The United States

Rhythm Pharmaceuticals' (NASDAQ:RYTM) investors will be pleased with their incredible 370% return over the last three years
RYTM

Simply Wall St.

10 months ago

Rhythm Pharmaceuticals' (NASDAQ:RYTM) investors will be pleased with their incredible 370% return over the last three years

RYTM

MT Newswires

10 months ago

Rhythm Pharmaceuticals Gains FDA Approval for Expanded IMCIVREE Use

Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential
RYTM

Benzinga

10 months ago

Rhythm Pharmaceuticals' Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old
RYTM

GlobeNewswire

10 months ago

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

RYTM

MT Newswires

10 months ago

Oppenheimer Initiates Coverage on Rhythm Pharmaceuticals With Outperform Rating, $76 Price Target

Rhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities
RYTM

TipRanks

a year ago

Rhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities

RYTM

MT Newswires

a year ago

Rhythm Pharmaceuticals Says Imcivree Receives Expanded Marketing Authorization in UK

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old

Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone
RYTM

Investor's Business Daily

a year ago

Biotech Stock Attempts To End Losing Streak, Lands Back in Buy Zone

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces Five Presentations at ESPE 2024, including New Real-world Data in Pediatric Patients with Acquired or Congenital Hypothalamic Obesity Treated with Setmelanotide

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

High Growth Tech Stocks Featuring Three Prominent US Companies
RYTM

Simply Wall St.

a year ago

High Growth Tech Stocks Featuring Three Prominent US Companies

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
RYTM

Simply Wall St.

a year ago

Rhythm Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
RYTM

GuruFocus.com

a year ago

Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates
RYTM

Zacks

a year ago

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Update

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know
RYTM

Zacks

a year ago

Will Allogene Therapeutics (ALLO) Report Negative Earnings Next Week? What You Should Know

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
RYTM

Zacks

a year ago

Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?
RYTM

Zacks

a year ago

ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock?

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 5, 2024

RYTM

MT Newswires

a year ago

Guggenheim Initiates Coverage on Rhythm Pharmaceuticals With Buy Rating, $70 Price Target

High Growth Tech Stocks to Watch in October 2024
RYTM

Simply Wall St.

a year ago

High Growth Tech Stocks to Watch in October 2024

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
RYTM

GlobeNewswire

a year ago

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
RYTM

Insider Monkey

a year ago

Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish

Share on Social Networks: